IL23R and IL12B SNPs and Haplotypes Strongly Associate with Crohn's Disease Risk in a New Zealand Population.
DNA samples from 339 Crohn's disease (CD) and 407 randomly selected controls from the Auckland (New Zealand) IBD project, were genotyped for five common single nucleotide polymorphisms in IL-23R (rs11805303, rs7517847, rs1343151, rs11209026, and rs10889677) and two in IL-12B (rs1363670 and rs6887695). While the IL-12B variants did not show an overall association and other IL23R variants led to minor changes in the risk of CD, rs1343151 and/or rs7517847 variants in the IL-23R gene strongly reduced the risk of developing CD at both allelic and genotype levels. A significantly decreased risk of first diagnosis of childhood CD was observed in individuals carrying the A allele of rs1343151, or between 17-40 y in individuals carrying the G allele in rs7517847 of IL-23R. A significantly decreased risk of ileocolonic or structuring disease was observed in individuals carrying the A allele in either rs11209026 or rs1343151, or the G allele in rs7517847 of IL-23R, and when such individuals did develop the disease, they were unlikely to require a bowel resection. Certain haplotypes very strongly modified risk. There was evidence for interactions of IL-23R variants with the NOD2 wild-type (d/d) genotype. Down-regulating the function of the IL-23R gene may decrease CD risk in the normal population.
Discipline of Nutrition, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, 1142, New Zealand.
Lynnette R
LR
Ferguson
Dug Yeo
DY
Han
Alan G
AG
Fraser
Claudia
C
Huebner
Wen Jiun
WJ
Lam
Angharad R
AR
Morgan
Science. 2006 Dec 1;314(5804):1403-5
17138888
J Clin Invest. 2006 May;116(5):1310-6
16670770
Gut. 2007 Aug;56(8):1173-4
17337463
Am J Gastroenterol. 2008 Mar;103(3):621-7
18047540
Microbes Infect. 2006 Apr;8(4):1167-73
16513390
Eur J Immunogenet. 2003 Oct;30(5):329-33
14641539
J Immunol. 2007 Jun 15;178(12):8138-47
17548652
Clin Gastroenterol Hepatol. 2007 Aug;5(8):972-6
17618837
J Mol Med (Berl). 2008 Jan;86(1):99-103
17901940
Autoimmunity. 2009 Feb;42(2):126-30
19021011
Mutat Res. 2010 Aug 7;690(1-2):139-44
20067801
Adv Biochem Eng Biotechnol. 2002;77:57-74
12227737
J Invest Dermatol. 2009 Feb;129(2):355-8
18800148
Methods Mol Biol. 2003;212:241-62
12491915
Nat Genet. 2007 Feb;39(2):207-11
17200669
Am J Pathol. 1997 Mar;150(3):823-32
9060820
Inflamm Bowel Dis. 2006 Oct;12(10):936-43
17012964
Inflamm Bowel Dis. 2007 May;13(5):511-5
17309073
J Immunol. 2006 Sep 1;177(5):2760-4
16920909
Mol Diagn. 2000 Dec;5(4):341-8
11172498
Annu Rev Immunol. 1998;16:495-521
9597139
World J Surg. 1998 Apr;22(4):382-9
9523521
Scand J Gastroenterol Suppl. 1989;170:2-6; discussion 16-9
2617184
Am J Gastroenterol. 2007 Dec;102(12):2754-61
17894849
PLoS Genet. 2008 Mar 28;4(3):e1000041
18369459
J Pediatr Gastroenterol Nutr. 2007 Oct;45(4):405-8
18030204
Am J Hum Genet. 2005 May;76(5):887-93
15789306
N Z Med J. 2008 Oct 03;121(1283):19-34
18841182
Biometrics. 1997 Dec;53(4):1253-61
9423247
J Clin Invest. 2006 May;116(5):1317-26
16670771
Expert Rev Clin Immunol. 2010 Jul;6(4):573-83
20594131
Nature. 2007 Jun 7;447(7145):661-78
17554300
J Immunol. 2002 Jun 1;168(11):5699-708
12023369
Gut. 2008 Dec;57(12):1682-9
18653729
J Hum Genet. 2007;52(7):575-583
17534574
J Invest Dermatol. 2008 Jul;128(7):1653-61
18219280
Mutat Res. 2010 Aug 7;690(1-2):123-38
20144628
Science. 2006 Dec 1;314(5804):1461-3
17068223
PLoS Genet. 2007 Apr 20;3(4):e58
17447842
Inflamm Bowel Dis. 2008 May;14(5):674-9
18200510
Gut. 2009 Aug;58(8):1152-67
19592695
J Exp Med. 1995 Nov 1;182(5):1281-90
7595199